期刊文献+

卡前列素氨丁三醇注射液联合缩宫素预防高危产妇剖宫产产后出血的临床研究 被引量:13

Clinical study on prevention of postpartum hemorrhage by cesarean section in high risk women with carboprost tromethamine injection combined with oxytocin
下载PDF
导出
摘要 目的探究采用卡前列素氨丁三醇注射液联合缩宫素预防高危产妇剖宫产产后出血的应用效果。方法选择本院高危产妇总计112例为对象开展研究,按照随机法将产妇分为研究组与对照组,各56例。两组均采用缩宫素,研究组加入卡前列素氨丁三醇注射液治疗,观察两组患者术后2h、24h的出血量,记录两组不良反应情况。结果研究组各时间段内的出血量相较对照组更低,数据对比差异有统计学意义(P<0.05);对照组不良反应率为7.14%,研究组为10.17%,两组不良反应发生率较小,且两组数据相近,组间比较差异无统计学意义。结论应用卡前列素氨丁三醇注射液联合缩宫素能够显著预防高危产妇剖宫产出血症状,且用药较为安全。 Objective To explore the application effect of Carboprost tromethamine injection combined with oxytocin in preventing postpartum hemorrhage of high-risk parturient by cesarean section.Methods A total of 112 high risk parturients in our hospital were selected.They were randomly divided into study group and control group,with 56 cases in each group.Both groups were treated with oxytocin,the study group was treated with carboprost tromethamine injection.The blood loss was observed at 2 h and 24 h after operation,and the adverse reactions were recorded in both groups.Results The amount of blood loss in the study group was lower than that in the control group(P<0.05),and the odds of adverse reaction in the control group was 7.14%,10.17%adverse reactions in the study group,and the data of the two groups were similar,there was no significant difference between the two groups.Conclusion The application of carboprost tromethamine injection combined with oxytocin can significantly prevent bleeding symptoms of cesarean section in high-risk women,and it is safe to use drugs.
作者 王贵娥 陈小飞 Wang Guie;Chen Xiaofei(Department of Obstetrics and Gynecology of Maternal and Child Health Hospital,Qichun County,Huanggang,Hubei,435300,China)
出处 《当代医学》 2019年第23期46-48,共3页 Contemporary Medicine
关键词 高危产妇 产后出血 卡前列素氨丁三醇注射液 缩宫素 High risk parturient Postpartum hemorrhage Carboprost tromethamine injection Oxytocin
  • 相关文献

参考文献8

二级参考文献71

  • 1邓巧云.产后出血相关危险因素的研究进展[J].中国药物经济学,2013,8(S3):514-516. 被引量:5
  • 2KawamuraA,Kondoh E,Hamanishi J,et al.Cervical clamp with ring forceps to prevent prolapse of an intrauterine balloon in the management of postpartum hemorrhage[J].J Obstet Gynaecol Res,2013,39(3):733-737.
  • 3Cirpan T,Sanhal C Y,Yiicebilgin S,et al.Conservative management of placenta previa percreta by leaving placental tissue in situ with arterial ligation and adjuvant methotrexate therapy[J].J Turk Ger Gynecol Assoc,2011,12(2):127-129.
  • 4Rathore A M,Gupta S,Manaktala U,et al.Uterine tamponade using condom catheter balloon in the management of non-traumatic postpartum hemorrhage[J].J Obstet Gynaecol Res,2012,38(9):1162-1167.
  • 5Markova V,Sorensen J L,Holm C,et al.Evaluation of multi-professional obstetric skills training for postpartum hemorrhage[J].Acta Obstet Gynecol Scand,2012,91(3):346-352.
  • 6Jung H N,Shin S W,Choi S J,al.Uterine artery embolization for emergent management of postpartum hemorrhage associated with placenta accreta[J].Acta Radiol,2011,52(6):638-642.
  • 7Roach MK,Abramovici A,Tita ATN.Dose and duration of oxytocin to prevent postpartum hemorrhage:a review[J].Am J Perinatol,2012,30(7):523-528.
  • 8Chaudhuri P,Biswas J,Mandal A.Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in lowrisk women[J].Int J Gynecol Obstet,2012,116(2):138-142.
  • 9Stanton CK,Newton S,Mullany LC,et al.Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject TM by peripheral health care providers at home births:Design of a community-based cluster-randomized trial[J].BMC Pregnancy Childbirth,2012,12(1):42.
  • 10Winikoff B,Dabash R,Durocher J,et al.Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour:a double-blind,randomised,non-inferiority trial[J].The Lancet,2010,375(9710):210-216.

共引文献213

同被引文献103

引证文献13

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部